HitGen (SHSE:688222) Short-Term Capital Lease Obligation : ¥0.0 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is HitGen Short-Term Capital Lease Obligation?

HitGen's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.0 Mil.

HitGen Short-Term Capital Lease Obligation Historical Data

The historical data trend for HitGen's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HitGen Short-Term Capital Lease Obligation Chart

HitGen Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

HitGen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

HitGen Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

HitGen Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of HitGen's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

HitGen (SHSE:688222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HitGen Inc (SHSE:688222) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18, Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093

Website

https://www.hitgen.com

HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

HitGen (SHSE:688222) Headlines

No Headlines